文献速递肝胆胰外科

巨大肝血管瘤的腹腔镜肝切除或剜除术:如何选择

Laparoscopic liver resection or enucleation for giant hepatic hemangioma: how to choose?
PubMed 文献 · Surg Endosc · 2024-04-15

该回顾性研究分析了2015年3月至2022年8月接受腹腔镜治疗的巨大肝血管瘤患者,比较腹腔镜肝切除(LR)与腹腔镜剜除(LE)的围手术期结局。共纳入LR组127例和LE组287例,发现LE组中位出血量高于LR组(300 vs 200 mL,P<0.001)。门脉期强化率(PER)≥38.9%的患者中,LR与更少出血相关(155 vs 400 mL,P<0.001);PER较低时两种术式围手术期结局相似。作者推荐PER高于38.9%的患者选择LR。

要点

  • LE组中位出血量高于LR组(300 vs 200 mL,P<0.001)
  • 出血量>400 mL的独立危险因素包括肿瘤≥10 cm、毗邻大血管、位于右肝或尾状叶、PER≥38.9%
  • PER≥38.9%的患者中LR出血量少于LE(155 vs 400 mL,P<0.001),作者推荐LR

核心结论

  • 腹腔镜LE和LR治疗巨大肝血管瘤均可行且安全;对于PER高于38.9%的患者,推荐LR。

研究设计与样本

  • 回顾性分析2015年3月至2022年8月接受腹腔镜治疗的巨大肝血管瘤患者,LR组127例,LE组287例。

主要发现

  • LE组中位出血量高于LR组(300 vs 200 mL,P<0.001)。
  • 出血量>400 mL的独立危险因素为肿瘤大小≥10 cm、肿瘤毗邻大血管、肿瘤占据右肝或尾状叶、门脉期强化率(PER)≥38.9%。
  • PER高的患者中,LR出血量少于LE(155 vs 400 mL,P<0.001);PER低的患者中两种术式围手术期结局相似。

关键数值与推荐

  • PER≥38.9%为出血量>400 mL的独立危险因素。
  • PER高于38.9%的患者推荐LR。

临床怎么用

  • 巨大肝血管瘤的腹腔镜治疗中,LE和LR均可选择;PER高于38.9%时作者推荐LR。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic treatment has been increasingly adopted for giant hepatic hemangioma (HH), but the role of liver resection or enucleation remains uncertain. The aim of this study is to compare the laparoscopic resection (LR) with laparoscopic enucleation (LE) for HH, and to provide evidence on how to choose the most suitable approach for HH. METHODS: A retrospective analysis of HH patients underwent laparoscopic treatment between March 2015 and August 2022 was performed. Perioperative outcomes were compared based on the surgical approaches, and risk factors for increased blood loss was calculated by logistic regression analysis. RESULTS: A total of 127 patients in LR group and 287 patients in LE group were enrolled in this study. The median blood loss (300 vs. 200 mL, P < 0.001) was higher in LE group than that in LR group. Independent risk factors for blood loss higher than 400 mL were tumor size ≥ 10 cm, tumor adjacent to major vessels, tumor occupying right liver or caudate lobe, and the portal phase enhancement ratio (PER) ≥ 38.9%, respectively. Subgroup analysis showed that LR was associated with less blood loss (155 vs. 400 mL, P < 0.001) than LE procedure in patients with high PER value. Both LR and LE approaches exhibited similar perioperative outcomes in patients with low PER value. CONCLUSIONS: Laparoscopic treatment for HH could be feasibly and safely performed by both LE and LR. For patients with PER higher than 38.9%, the LR approach is recommended.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zhang H, Xu H, Wen N, et al. Laparoscopic liver resection or enucleation for giant hepatic hemangioma: how to choose? Surg Endosc. 2024. PMID: 38622227. doi:10.1007/s00464-024-10820-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。